ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,990,601 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.83 68.14B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.14 billion. Gsk has a price to earnings ratio (PE ratio) of 13.83.

Gsk Share Discussion Threads

Showing 13451 to 13470 of 33100 messages
Chat Pages: Latest  544  543  542  541  540  539  538  537  536  535  534  533  Older
DateSubjectAuthorDiscuss
05/12/2016
09:27
Thanks for the down-tick. You know I am right but you don't like what I say.
minerve
05/12/2016
09:23
Next it will be full-scale support of boob-job, tattoos and Botox reversals. Still the kids with the rare cancers can die.
minerve
05/12/2016
09:19
People are very quick to target obese people but many have hormonal and thyroid disorders that don't help their condition. Society ostracizes them leading to anxiety and poor self-esteem in which they then seek more comfort in food. And the cycle repeats itself. Same with mental health conditions. People would generally be healthier and savings would be had by the NHS if society was more accepting of people who didn't fit the current fad of gay, fit and 'plastic looking' like effigies of Ken & Barbie.
minerve
05/12/2016
09:16
Yup as with smoking which was nearly 40 a day at one point, 15 years ago now.

Anyway I suppose we all have faults, however I think the future of healthcare
will see some type of rationing, if your BMI is over a certain level you
already do not qualify for certain operations - in fairness there is often good
clinical reasons for this, patient safety with anaesthetics etc.

essentialinvestor
05/12/2016
09:12
EI - the magic word is "previously" - so you have obviously done something about it
ttg100
05/12/2016
09:10
What about the health freaks? Breaking limbs, cycling accidents and so on. They are going to look really funny in a decade or so lying in hospital dying of nothing.
minerve
05/12/2016
09:03
ttg, my point really is where do you draw the line.

I've been overweight previously so not mentioning it in a holier than thou way.

essentialinvestor
05/12/2016
09:01
Just have a walk round places like Asda and see how many extremely obese people pick up trays of doughnuts - as a type 1 diabetic with no choice it makes me really really angry !!!!!
ttg100
05/12/2016
08:55
My other half arranged social care last week for lady born in 1960,
who due to morbid obesity suffers from chronic leg ulcers, COPD and needs an
oxygen supply at home on hand. Two careers seven days a week for 30 minutes
morning and evening, all paid for by the state. On disability benefit, entirely self
inflicted due to lifestyle choices.

essentialinvestor
04/12/2016
14:41
Obesity treatments are going to dwarf anything else the way waistlines
are going.


The oncology compounds mentioned in Fierce Pharma cost between $70,000-$170,000
per course of treatment. The medium improvement in overall survival rates was 2.1
months. Only one drug was found to improve quality of life.


Looks like an interesting open tomorrow.

essentialinvestor
04/12/2016
14:12
There is a damming report in Fierce Pharma on the lack of effectiveness
of many oncology drugs approved between 2008-2012.

It is shocking read, particularly in the context of the huge cost of these
treatments.


PREP to be made available on the NHS in a 3 year 10,000 person trial,
the ViiV Prep product has just entered Phase 111 from memory.

essentialinvestor
04/12/2016
08:46
https://www.theguardian.com/business/2016/dec/02/glaxosmithkline-andrew-witty-companies-arent-doing-as-much-as-people-would-like
xtrmntr
02/12/2016
21:56
EI, sorry missed that, scanned too quickly!
ianood
02/12/2016
19:36
Ian, yes as mentioned they offered an undisclosed price cut, so their
additional cost/benefit data was based on this.
It underscores the point mentioned yesterday about pharma having to increasingly
show cost/benefit for approval of new medications.

With their Lupus treatment NICE reportedly only gave approval following 3 price cuts
by GSK.

essentialinvestor
02/12/2016
17:33
EI - and the price that the NHS is paying has not bee disclosed.
ianood
02/12/2016
14:33
May have been mentioned- NICE issued draft approval for Nucala this week
changing their previous decision. GSK provided more data on cost effectiveness
and offered an undisclosed price cut. The standard cost is £840 per dose.

More than 100,000 people in the UK suffer from asthma that cannot be treated with
with regular medicines.
A dose of Nucela is given every 4 weeks.

Although the standard price appears high, would think many of those 100,000 patients will
end up in A&E on a regular basis, some requiring inpatient monitoring and treatment.


See what happens Sunday, Monday may be interesting!.

essentialinvestor
02/12/2016
11:42
Agreed, Waiting for monday here and on AZN.
philo124
02/12/2016
10:00
Perhaps worth leaving some for next week Essential - just in case of Italy going pear shape! 😉
minerve
02/12/2016
09:59
Morning everyone . GSK and BATS this morning for me.
philanderer
02/12/2016
09:57
My better half deals with COPD cases almost daily in her work,
it really is a pernicious illness and also progressive.

Added some more GSK near the open and also some DGE.

essentialinvestor
Chat Pages: Latest  544  543  542  541  540  539  538  537  536  535  534  533  Older

Your Recent History

Delayed Upgrade Clock